Fact CheckerSign in

NCT07556419Not yet recruiting

Development of a Mobile Application Called TansiyoRitim for Hypertension Patients

The Effect of a Mobile Application Developed for Hypertension Patients on Blood Pressure Control, Treatment Adherence, and Self-Efficacy: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 18 Jun 2026

Brief summary (registry, in English)

Based on King's Theory of Goal Success, this project is designed to develop a mobile application called TansiyoRitim for individuals over the age of 18 diagnosed with hypertension. The research consists of the following phases: creating educational content, designing the mobile application, and evaluating the application and its effectiveness. Within the scope of the research, participants' blood pressure control, self-efficacy levels, and treatment adherence behaviors will be assessed using valid and reliable measurement tools, and the goal is to support these behaviors through the developed mobile health application. Participants' clinical treatment processes, pharmacological treatment adjustments planned by the physician, and changes in medication dosages will be excluded from the scope of the project. No intervention will be made in the medical treatment currently being administered during the study; participants' routine clinical follow-up and treatment processes will continue within the framework of standard care. Only educational and mobile app-based supportive interventions will be implemented within the scope of the research.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
160 (estimated)
First submitted
28 Mar 2026
Start date
1 Jul 2026
Primary completion date
30 Oct 2026
Lead sponsor
Kafkas University
NCT number
NCT07556419

What you commit to

  • Study type: Interventional
  • Planned participants: 160
  • From 1 Jul 2026 to the primary completion date, 30 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of severe comorbid chronic disease affecting participation
  • Severe physical or cognitive impairment preventing participation

Age

  • Age under 18 or over 85 years

Other

  • Body mass index (BMI) ≥ 30 kg/m²

Who the study is looking for

  • Diagnosed with hypertension at least 1 year prior to enrollment
  • Currently using antihypertensive medication
  • Able to use a smartphone
  • Able to measure blood pressure at home
  • No severe visual or hearing impairment
  • Able to communicate in Turkish
  • Literate
  • Willing to participate and provide informed consent

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kafkas University
Coordinator of this site? Confirm its status
KarsTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.